News for 'pharmaceutical drugs'

Toxins in cough syrups, other drugs due to plastic bottling

Toxins in cough syrups, other drugs due to plastic bottling

Rediff.com1 Jun 2016

Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.

'Why the fuss over hydroxychloroquine?'

'Why the fuss over hydroxychloroquine?'

Rediff.com7 Apr 2020

'India is a pharma dada. We can manufacture enough for our people and for the world.'

Eli Lilly sues Sun Pharma over patent

Eli Lilly sues Sun Pharma over patent

Rediff.com2 Apr 2007

Eli Lilly and Company, the US-based multinational pharmaceutical major, has sued Sun Pharmaceuticals in the US, alleging the company infringed its patent on Gemzar, a blockbuster cancer drug.

India's richest club sees nine new entrants; Ambani still No 1

India's richest club sees nine new entrants; Ambani still No 1

Rediff.com9 Oct 2020

Half of the nation's 100 richest saw gains rising a collective 14% to $517.5 billion, says Forbes. Forbes released 2020's top 100 richest Indians on Thursday, which included newcomers, Sanjeev Bikhchandani, co-founder of Info Edge (India), who owns popular job and property websites; siblings Nithin and Nikhil Kamath, co-founders of discount stock brokerage Zerodha Broking, and three specialty chemicals producers - Vinod Saraf, founder of Vinati Organics, Arun Bharat Ram, the patriarch of SRF, and brothers Chandrakant and Rajendra Gogri of Aarti Industries. Other newcomers included Delhi-based brothers Ramesh Kumar and Mukand Lal Dua of Relaxo Footwears, which owns affordable footwear brands; dairyman, R G Chandramogan of Hatsun Agro; Premchand Godha, who chairs IPCA Laboratories, manufacturing formulations, bulk drugs and drug intermediates; G Rajendran, founder of jewellery chain, GRT Jewellers.

BSE: Top gainers and losers

BSE: Top gainers and losers

Rediff.com20 Jul 2016

Sentiment also remained buoyant as a good monsoon season lifted hopes of a revival in farm output.

Pfizer seeks approval in India for Covid vaccine

Pfizer seeks approval in India for Covid vaccine

Rediff.com6 Dec 2020

'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'

As India records 2.34 lakh Covid cases, PM urges: Test, track, treat

As India records 2.34 lakh Covid cases, PM urges: Test, track, treat

Rediff.com17 Apr 2021

Top officers across various ministries participate in the meeting that started at 8 pm on Saturday. The meeting is currently underway. The country is currently witnessing a second and more severe wave of the pandemic.

Drug firms wary of patents edict

Drug firms wary of patents edict

Rediff.com24 Dec 2004

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

Pricing body takes pharma firms to task

Pricing body takes pharma firms to task

Rediff.com9 Jan 2008

Refusing to divulge identity of the companies, sources indicated that three of them are based in Delhi and the remaining are in Maharashtra.

Covid vaccines for children likely by Sept: AIIMS chief

Covid vaccines for children likely by Sept: AIIMS chief

Rediff.com24 Jul 2021

The trial is being conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12 to 18 years followed by the age group of 6 to 12. Trials for children between the ages of and 2-6 years are currently undergoing trials.

Why govt lets MNCs sell insulin at a higher price

Why govt lets MNCs sell insulin at a higher price

Rediff.com8 Feb 2013

The drug regulator recently asked some domestic companies to cut prices of insulin while MNCs, which are major players, are allowed to set their own price for the drug.

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Rediff.com28 Dec 2021

Biological E Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the Hyderabad-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday.

US regulator frowns on Sun-Ranbaxy deal

US regulator frowns on Sun-Ranbaxy deal

Rediff.com31 Jan 2015

The proposed merger would likely harm future competition

Golay's tricky road ahead

Golay's tricky road ahead

Rediff.com13 Jun 2019

Sikkim's new chief minister will have to achieve growth without compromising nature.

Pharma firms spend 10% of production cost on tie-ups

Pharma firms spend 10% of production cost on tie-ups

Rediff.com20 Aug 2012

This helps consumers check the authenticity of drugs simply by sending SMSes.

Big pharmas' mega plan to beat competition in US

Big pharmas' mega plan to beat competition in US

Rediff.com20 Feb 2017

Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.

Why pharma companies sell sub-standard stuff in India

Why pharma companies sell sub-standard stuff in India

Rediff.com6 May 2016

The big companies too are responsible for the sub-standard drugs in the market.

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Rediff.com13 Mar 2014

Recently, Ranbaxy and Wockhardt too were hauled up.

7 Foods Diabetics Should Avoid

7 Foods Diabetics Should Avoid

Rediff.com14 Nov 2022

Starting your day with breakfast cereals or granola bars is something diabetic patients should totally avoid.

'Maligning the medical fraternity was not expected of PM'

'Maligning the medical fraternity was not expected of PM'

Rediff.com22 Apr 2018

The Indian Medical Association and the Mumbai Association of Medical Consultant have written a letter to Narendra Modi expressing disappointment over his statement during the Bharat ki Baat Sabke saath event in London.

Zydus may set up US facility

Zydus may set up US facility

Rediff.com21 Jan 2005

Why India must hike R&D spending

Why India must hike R&D spending

Rediff.com19 Jan 2007

While the domestic industry needs to increase its R&D spending quite dramatically, price controls will only cripple the sector.

Sun Pharma keen to enter Japan's generics market

Sun Pharma keen to enter Japan's generics market

Rediff.com6 Mar 2014

Is yet to decide about the partnership or acquisition route

Drug patents? India is 2nd globally

Drug patents? India is 2nd globally

Rediff.com16 Aug 2005

India has received 1,312 applications for patent of pharmaceutical products, becoming only the second country after the US to get a large number such requests.

PM to meet COVID-19 vaccine manufacturers on today

PM to meet COVID-19 vaccine manufacturers on today

Rediff.com20 Apr 2021

During the meeting, scheduled to be held through video conference at 6 pm on Tuesday, the Department of Biotechnology will make a presentation and also coordinate with all the participants, sources added.

Dilip Shangvi down Rs 90,840 crores in two years!

Dilip Shangvi down Rs 90,840 crores in two years!

Rediff.com8 Jun 2017

An end to Sun Pharma founder Dilip Shanghvi's woes are not in sight.

Sun Pharma open to large acquisitions post Ranbaxy

Sun Pharma open to large acquisitions post Ranbaxy

Rediff.com25 Mar 2015

Sun Pharma open to large acquisitions post Ranbaxy.

Alpharma to sell Orchid drugs in US

Alpharma to sell Orchid drugs in US

Rediff.com24 Feb 2005

Orchid Chemicals and Pharmaceuticals Ltd has entered into an exclusive agreement with Alpharma Inc for marketing its select non-antibiotic generic formulations in the US and Europe.

Pharma industry bounces back to good health

Pharma industry bounces back to good health

Rediff.com12 Jun 2018

In May, price growth for drugs was in negative territory at (-)1 per cent

India withdraws policy to cap nonessential pharma prices

India withdraws policy to cap nonessential pharma prices

Rediff.com23 Sep 2014

Ties between India and the United States have been strained in recent years because of trade policies and patent disputes.

Cornerstone to sell Lupin drug in US

Cornerstone to sell Lupin drug in US

Rediff.com27 Jan 2005

Lupin Pharmaceuticals Inc, the wholly owned subsidiary of Lupin, has entered into an alliance with Cornerstone BioPharma Inc.

Wockhardt gets import alert from US FDA

Wockhardt gets import alert from US FDA

Rediff.com6 Aug 2016

Ankleshwar plant is the third such facility to face action

India's reaction myopic, irrational, says Ranbaxy whistle-blower

India's reaction myopic, irrational, says Ranbaxy whistle-blower

Rediff.com21 Mar 2014

Ranbaxy whistleblower Dinesh Thakur tells Aziz Haniffa that a formal Congress hearing on spurious drugs from India is being sought.

How Indian pharma bounced back from lockdown lows

How Indian pharma bounced back from lockdown lows

Rediff.com7 Dec 2020

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies - Indian drug makers have shown that medicine sales is certainly a sunshine sector.

India lifts temporary ban on supply of hydroxychloroquine

India lifts temporary ban on supply of hydroxychloroquine

Rediff.com7 Apr 2020

India on Tuesday temporarily licensed the export of paracetamol and anti-malarial drug Hydroxychloroquine in appropriate quantities to some countries, which have been particularly badly affected by the coronavirus pandemic.

Teva to sell Ranbaxy drug in US

Teva to sell Ranbaxy drug in US

Rediff.com16 Dec 2004

Ranbaxy Laboratories on Thursday announced that Teva Pharmaceuticals, under a mutual agreement with the Indian pharma major, has commercially launched its Quinapril HCL tablets in the US.

Patents: Nestle,Takeda sue Lupin, Torrent

Patents: Nestle,Takeda sue Lupin, Torrent

Rediff.com9 Jul 2009

In another development, leading Japanese drug maker Takeda Pharmaceutical sued Ahmedabad-based Torrent Pharma in the US for infringing seven patents covering its flagship diabetes drug, Actos. Oracea (doxycycline) is the only US Food and Drug Administration approved oral drug to treat rosacea -- a skin disorder in the face with inflammation, skin redness and spider veins.

4 Habits To Keep Your Heart Healthy

4 Habits To Keep Your Heart Healthy

Rediff.com9 Nov 2022

Food (ahara) and lifestyle (vihara) have a major impact on the health of your heart.